603579 荣泰健康
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)4.6549.63810.5719.01713.757
总资产报酬率 ROA (%)3.1265.3865.9544.9017.589
投入资产回报率 ROIC (%)3.5986.3596.9785.9779.758

边际利润分析
销售毛利率 (%)32.09531.68030.54726.52426.836
营业利润率 (%)11.23013.17612.7209.30410.152
息税前利润/营业总收入 (%)12.81212.15311.6067.87711.384
净利润/营业总收入 (%)9.65612.01210.9618.2168.728

收益指标分析
经营活动净收益/利润总额(%)43.86977.07092.71298.25280.532
价值变动净收益/利润总额(%)37.42315.5715.66716.71538.127
营业外收支净额/利润总额(%)0.889-0.194-2.504-3.994-1.633

偿债能力分析
流动比率 (X)3.6812.2103.3422.5512.338
速动比率 (X)3.4002.0563.1252.3202.018
资产负债率 (%)17.81546.13641.71245.38045.693
带息债务/全部投入资本 (%)5.23833.88226.70334.94128.041
股东权益/带息债务 (%)1,765.271186.444258.827180.349250.053
股东权益/负债合计 (%)460.743116.664139.450120.110118.600
利息保障倍数 (X)8.648-12.191-14.461-7.3628.160

营运能力分析
应收账款周转天数 (天)38.48440.22424.10321.34417.304
存货周转天数 (天)51.98348.94248.90759.23849.676